Evangelisches Waldkrankenhaus Spandau Krankenhausbetriebs gGmbH

The medical center is at the forefront of breast cancer research, focusing on innovative therapies for HER2+ early breast cancer. The center is exploring the efficacy of trastuzumab-deruxtecan compared to traditional chemotherapy regimens, aiming to improve pathologic complete response rates and long-term survival outcomes.

• HER2+ early breast cancer
• Trastuzumab-deruxtecan therapy
• Pathologic complete response

Through its research, the center is contributing to personalized treatment strategies that enhance patient outcomes in breast cancer care.

Specializing in endometrial cancer, the center is refining adjuvant treatments based on molecular features. The focus is on mismatch-repair deficient high-risk endometrial cancer, aiming to improve recurrence-free survival through tailored therapeutic approaches.

• Mismatch-repair deficient endometrial cancer
• Adjuvant treatment refinement
• Recurrence-free survival

This research is pivotal in advancing the understanding and management of high-risk endometrial cancer, offering hope for improved patient prognoses.

The center is pioneering research in rectal cancer, comparing preoperative chemotherapy with risk-adapted postoperative approaches. The goal is to enhance disease-free survival in patients with locally advanced rectal cancer, optimizing treatment protocols for better outcomes.

• Locally advanced rectal cancer
• Preoperative chemotherapy
• Disease-free survival

By investigating these strategies, the center is contributing to more effective and individualized treatment plans for rectal cancer patients.

Focusing on organ preservation in intermediate and high-risk rectal cancer, the center is evaluating the efficacy of short-course radiotherapy versus chemoradiotherapy. The aim is to improve organ preservation rates while maintaining survival and quality of life.

• Intermediate and high-risk rectal cancer
• Short-course radiotherapy
• Organ preservation

This research is crucial in developing less invasive treatment options that prioritize patient quality of life.

The center is advancing research in thromboprophylaxis for patients undergoing hip arthroplasty. By investigating reduced duration anticoagulation protocols, the center aims to maintain efficacy in preventing venous thromboembolism while minimizing treatment duration.

• Hip arthroplasty
• Enhanced recovery protocols
• Venous thromboembolism prevention

This research supports the development of optimized care pathways that enhance recovery and reduce complications in orthopedic surgery.

In the realm of colon cancer, the center is investigating the benefits of preoperative systemic therapy. The research aims to determine the efficacy of chemotherapy before surgery compared to traditional postoperative approaches, potentially improving treatment outcomes for advanced colon cancer.

• Advanced colon cancer
• Preoperative systemic therapy
• Stage-guided adjuvant therapy

Through this research, the center is contributing to the evolution of treatment paradigms that enhance survival and quality of life for colon cancer patients.